Coverage route / questions for the insurer
Ask your plan about cover for the proposed use
Give your plan both the drug’s name and the reason for the prescription. Ask what needs approval before the pharmacy supplies the medicine, and what you would pay.
Medicare payment rules as of September 2026.
Ordinary Medicare drug cover versus the temporary Bridge
Ordinary drug cover: Part D
Medicare’s Part D drug benefit excludes medicines when used for weight loss under the law checked in September 2026.
Cover may be available for other accepted uses. Payment requires the medicine to be on the plan’s drug list and its approval requirements to be met.
Ask which use the prescription states.
The separate Bridge programme
The temporary programme offers certain weight-loss medicines at a $50 monthly payment for eligible people under the September 2026 terms.
The programme’s last day is December 31, 2027; it begins on July 1, 2026. Payments take place outside ordinary Part D.
Ask the person treating you to check the programme’s eligibility rules.
The law allows Part D to pay for some uses other than weight loss. Your own plan still has to include the drug on its list and agree to payment.
Read the records behind this ↓Who qualifies for the Bridge?
The September 2026 criteria consider age, weight, health history and plan type, and require a prescription and approval in advance.
A person with type 2 diabetes, a condition with high blood sugar, is excluded because that treatment belongs with ordinary Part D cover.
Ask the person treating you what health problem the prescription names and which payment rules apply to it.
Which products does the Bridge include?
As of September 2026, the programme includes semaglutide (Wegovy) as pills and shots, tirzepatide (Zepbound) as the KwikPen, and orforglipron (Foundayo) pills.
It excludes the single-dose Zepbound pens and vials under those September 2026 terms.
The small bottle holding a medicine is called a vial. Ask which exact product and type, such as a pill or shot, the prescription names before checking payment.
Does that payment help reach the yearly insurance limit?
Under September 2026 terms, paying the Bridge’s $50 does not bring you closer to Part D’s out-of-pocket limit. The programme also provides no low-income subsidy.
Out-of-pocket means money you pay yourself. A subsidy is help with that payment. Ask the plan to explain the cost over the whole proposed course of care.
What about Medicaid or another plan?
CMS, the federal agency for Medicare and Medicaid, calls its voluntary programme BALANCE. Through it, CMS negotiates medicine prices and insurance-payment terms for state Medicaid programmes and Medicare drug plans. As of September 2026, CMS named no state that had joined.
Medicaid is public health insurance run through state programmes. BALANCE does not guarantee that any one person’s medicine will be paid for. Ask your Nevada plan whether it has joined and what it pays for your medicine.
Ask the plan for its current drug list, the approval process and your payment. Keep the answer with the clinic’s estimate.
Words to use on the call
Your plan calls its list of medicines it covers a formulary. Prior authorization means the plan needs to agree before it pays.
Does my plan list this particular product as covered for the use being proposed?
Who sends the request for approval, and what records are needed?
What do I owe for the medicine, visits and tests separately?
If payment is refused, how can I ask the plan to review that decision?
Notes for this page
These notes use the rules and care records checked in September 2026.
A · The ordinary drug-cover proposal was not finalised
CMS: Medicare drug-benefit rule explanation ↗B · The separate programme and payment
CMS: Medicare Bridge details ↗C · The eligibility check belongs with the full criteria
CMS: Bridge rules for people providing care ↗D · How the Bridge payment fits with the plan
CMS: Bridge information for drug plans ↗E · States choosing whether to join BALANCE
CMS: BALANCE programme information ↗